Science Market Update

UCSD Clinical Trial of New Treatment for Blood Cancers

Posted by Gloria Beverage on Thu, Jul 05, 2018

Researchers at the University of California San Diego School of Medicine are hopeful the combination of the experimental drug cirmtuzumab along with ibrutinub can halt the progression of chronic B-cell cancers. In an article published in the June 1 issue of Cell Stem Cell, researchers reported that treatment of 26 chronic leukemia patients with the experimental drug combination appeared to stop the disease’s progress.

Read More

Tags: CA, University of California San Diego, San diego Biotech, Bioresearch product fair, San Diego, SDVS, UCSD, Research Funding, Biotechnology Vendor Showcase, laboratory equipment suppliers, cancer reserach, 2018, life sciecne, Blood Cancer, san diego research

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News